ArkeaBio, livestock vaccines, and mRNA.
Say hello to ArkeaBio. They’re a start-up seeking to create vaccines to decrease the effects of cow farts in order to fight climate change. I really am not making this up, it’s right there on their website.
Perhaps they’re not quite as explicit as I in their description, but regardless. ArkeaBio have incredibly received venture capital funding for what sounds like the kind of joke my 8 year old would crack in his classroom. And rather a lot of that.
Breakthrough Venture invested $12m in the cow fart vaccine venture. Yes, really.
No point in diving into who Breakthrough are, I previously covered them here. It’s the Billionaire Foundation class yet again.
Back in May, 2023, there was a story related to studying mRNA and livestock vaccines. In fact, in was announced that a project had received funding. I don’t really care about the MSM’s goalpost moves on this topic, they’re there to lie. No, this took place, and a project is funded with this in mind, explicitly.
So, with that in mind - exactly what kind of technology will ArkeaBio employ? Naturally, being a start-up, there’s absolutely no information on the topic. I wouldn’t expect as much. But given the start-up being connected the Billionaire Foundation class, one’s mind start to wander…
We obviously can’t just call and ask, because we’d almost certainly be met with a roaring laugh, but what we can do is look at material available on the web. Specifically - who works for said company?
The CEO is ‘Colin South’, who has previously worked with ‘enVolv’ and ‘Zymergen’. His experience reveals synthetic biology, genome engineering, and production of enhancing health, environment and food. Not going to comment on the latter, but the only difference between genome and genetic engineering is the introduction of foreign material.
Zymergen bought our enVolv, and their focus? GMO - genetics. Output of the company sold to the pharma industry - oh, and DARPA. I found that of interest, though won’t take it further for the time being.
Now, Zymergen failed to deliver, and ultimately, were bought out to while flirting with bankruptcy. More on that in a bit.
Another employee is this chap. Synthetic biology. Directed evolution. Genome engineering.
And another one. Directed evolution, protein engineering, and genetics again. Oh yeah, and liposomal drug delivery systems.
There are others, but let’s leave it at that. It somewhat suggests the direction of the company, highly secretive though it is.
Briefly back to Zymergy, who were on the brink of bankruptcy. They were rescued by Ginkgo Bioworks, who are in the media on occasion. Browsing their website, they have all sorts of worrying clients. Not sure about you - I don’t in particular want to be ‘secured’ by governments pushing through authoritarian legislation on behalf of the pharmaceutical industry.
As for being in the media - here’s a story from 2021. Synthetic biology, messenger RNA, and they supply mRNA ‘vaccine’ manufacturers.
A different article around the same time announced they were working wih Aldevron on mRNA manufacturing.
And Aldevron? Who are they? They are ‘part of the Danaher family’, and supplied the ‘linearized DNA template for Moderna’s COVID-19 vaccine‘.
In other words, that trail leads right into Moderna and mRNA in general.
So, time to sum up these findings.
-
The VP of Strategy of Zymergen left in late 2021, around the time the previous CEO was fired, to found ArkeaBio. He’s the currently acting CEO.
His old company was eventually bought out by a Ginkgo Bioworks, who supply Moderna with key tech relating to their mRNA vaccines.
And he employs people with expertise in genome engineering, directed evolution, and liposomal drug delivery systems.
-
So with that in mind - you think ArkeaBio’s tech just might be mRNA?
Or would that be a conspiracy theory?